FDA considers adding a dozen peptides to its bulk drug compounding list RAPS When will the FDA reclassify BPC 157 to Category 1 Octagon AI BPC 157 & TB 500 Blend 10mg 10mg Peptide Tech FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Schedules July 2026 PCAC Review of BPC 157, TB 500, MOTs C, KPV, Semax, Epitalon, DSIP PeptideRundown